Table of Contents Global Antipsychotic Medications Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Antipsychotic Medications Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Antipsychotic Medications Segment by Type 1.2.1 Selective Serotonin Reuptake Inhibitors (SSRIs) 1.2.2 Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) 1.2.3 Tricyclic Antidepressants (TCAs) 1.2.4 Monoamine Oxidase Inhibitors (MAOIs) 1.2.5 Reversible Inhibitors of Monoamine Oxidase-A (RIMA) 1.2.6 Tetracyclic Antidepressants (TeCAs) 1.2.7 Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) 1.3 Market Analysis by Application 1.3.1 Hospital Pharmacies 1.3.2 Drug Stores 1.3.3 Others 1.4 Overview of Global Antipsychotic Medications Market 1.4.1 Global Antipsychotic Medications Revenue (2015-2025) 1.4.2 Global Antipsychotic Medications Production and Capacity (2015-2025) 1.4.3 North America Antipsychotic Medications Status and Prospect (2015-2025) 1.4.4 Europe Antipsychotic Medications Status and Prospect (2015-2025) 1.4.5 Japan Antipsychotic Medications Status and Prospect (2014-2025) 1.4.6 China Antipsychotic Medications Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Antipsychotic Medications Industry Impact 1.6.1 How the Covid-19 is Affecting the Antipsychotic Medications Industry 1.6.2 Antipsychotic Medications Business Impact Assessment - Covid-19 1.6.3 Market Trends and Antipsychotic Medications Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Antipsychotic Medications Market Competition by Manufacturer 2.1 Global Antipsychotic Medications Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Antipsychotic Medications Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Antipsychotic Medications Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Antipsychotic Medications Manufacturer Market Share 2.5 Top 10 Antipsychotic Medications Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Antipsychotic Medications Market 2.7 Key Manufacturers Antipsychotic Medications Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Antipsychotic Medications Industry Key Manufacturers 3.1 Johnson and Johnson 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Johnson and Johnson Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Johnson and Johnson News 3.2 Eli Lilly 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Eli Lilly Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Eli Lilly News 3.3 Bristol-Myers Squibb 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Bristol-Myers Squibb Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Bristol-Myers Squibb News 3.4 AstraZeneca 3.4.1 Company Details 3.4.2 Product Information 3.4.3 AstraZeneca Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 AstraZeneca News 3.5 Novartis 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Novartis Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Novartis News 3.6 Allergan 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Allergan Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Allergan News 3.7 Pfizer 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Pfizer Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Pfizer News 3.8 GlaxoSmithKline 3.8.1 Company Details 3.8.2 Product Information 3.8.3 GlaxoSmithKline Antipsychotic Medications Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 GlaxoSmithKline News 4 Global Antipsychotic Medications Market Size Categorized by Regions (2015-2020) 4.1 Global Antipsychotic Medications Sales Market Share by Region 4.2 Global Antipsychotic Medications Revenue Market Share by Region (2015-2019) 4.3 Global Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Antipsychotic Medications Market Size Detail 4.4.1 North America Antipsychotic Medications Sales Growth Rate (2015-2020) 4.4.2 North America Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Antipsychotic Medications Market Size Detail 4.5.1 Europe Antipsychotic Medications Sales Growth Rate (2015-2020) 4.5.2 Europe Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Antipsychotic Medications Market Size Detail 4.6.1 Japan Antipsychotic Medications Sales Growth Rate (2015-2020) 4.6.2 Japan Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Antipsychotic Medications Market Size Detail 4.7.1 China Antipsychotic Medications Sales Growth Rate (2015-2020) 4.7.2 China Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Antipsychotic Medications Market Segment by Type 5.1 Global Antipsychotic Medications Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Antipsychotic Medications Sales and Market Share by Type (2015-2020) 5.1.2 Global Antipsychotic Medications Revenue and Market Share by Type (2015-2020) 5.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Sales Growth Rate and Price 5.2.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Sales Growth Rate (2015-2020) 5.2.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Price (2015-2020) 5.3 Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Sales Growth Rate and Price 5.3.1 Global Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Sales Growth Rate (2015-2020) 5.3.2 Global Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Price (2015-2020) 5.4 Tricyclic Antidepressants (TCAs) Sales Growth Rate and Price 5.4.1 Global Tricyclic Antidepressants (TCAs) Sales Growth Rate (2015-2020) 5.4.2 Global Tricyclic Antidepressants (TCAs) Price (2015-2020) 5.5 Monoamine Oxidase Inhibitors (MAOIs) Sales Growth Rate and Price 5.5.1 Global Monoamine Oxidase Inhibitors (MAOIs) Sales Growth Rate (2015-2020) 5.5.2 Global Monoamine Oxidase Inhibitors (MAOIs) Price (2015-2020) 5.6 Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Sales Growth Rate and Price 5.6.1 Global Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Sales Growth Rate (2015-2020) 5.6.2 Global Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Price (2015-2020) 5.7 Tetracyclic Antidepressants (TeCAs) Sales Growth Rate and Price 5.7.1 Global Tetracyclic Antidepressants (TeCAs) Sales Growth Rate (2015-2020) 5.7.2 Global Tetracyclic Antidepressants (TeCAs) Price (2015-2020) 5.8 Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Sales Growth Rate and Price 5.8.1 Global Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Sales Growth Rate (2015-2020) 5.8.2 Global Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Price (2015-2020) 6 Global Antipsychotic Medications Market Segment by Application 6.1 Global Antipsychotic Medications Sales Market Share by Application (2015-2020) 6.2 Hospital Pharmacies Sales Growth Rate (2015-2020) 6.3 Drug Stores Sales Growth Rate (2015-2020) 6.4 Others Sales Growth Rate (2015-2020) 7 Antipsychotic Medications Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Antipsychotic Medications Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Antipsychotic Medications Market Forecast 8.1 Global Antipsychotic Medications Sales, Revenue Forecast 8.1.1 Global Antipsychotic Medications Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Antipsychotic Medications Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Antipsychotic Medications Price and Trend Forecast (2020-2025) 8.2 Global Antipsychotic Medications Sales Forecast by Region (2020-2025) 8.2.1 North America Antipsychotic Medications Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Antipsychotic Medications Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Antipsychotic Medications Production, Revenue Forecast (2020-2025) 8.2.4 China Antipsychotic Medications Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Antipsychotic Medications Picture Table Global Antipsychotic Medications Sales by Type Figure Global Sales Market Share of Antipsychotic Medications by Product Type in 2019 Table Breakdown of Antipsychotic Medications by Company Type (Tier 1, Tier 2 and Tier 3) Figure Antipsychotic Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Selective Serotonin Reuptake Inhibitors (SSRIs) Picture Figure Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Picture Figure Tricyclic Antidepressants (TCAs) Picture Figure Monoamine Oxidase Inhibitors (MAOIs) Picture Figure Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Picture Figure Tetracyclic Antidepressants (TeCAs) Picture Figure Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Picture Table Global Antipsychotic Medications Sales by Application Figure Global Antipsychotic Medications Sales Market Share by Application in 2019 Figure Hospital Pharmacies Picture Figure Drug Stores Picture Figure Others Picture Table Antipsychotic Medications Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Antipsychotic Medications Revenue (Million US$) (2015-2025) Figure Global Antipsychotic Medications Production (K Units) (2015-2025) Figure North America Antipsychotic Medications Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Antipsychotic Medications Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Antipsychotic Medications Revenue (Million US$) Growth Rate (2014-2025) Figure China Antipsychotic Medications Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Antipsychotic Medications Sales by Manufacturer (2018-2020) Figure Global Antipsychotic Medications Sales Market Share by Manufacturer in 2019 Table Global Antipsychotic Medications Revenue by Manufacturer (2018-2020) Figure Global Antipsychotic Medications Revenue Market Share by Manufacturer in 2019 Table Global Antipsychotic Medications Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Antipsychotic Medications Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Antipsychotic Medications Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Antipsychotic Medications Market Table Key Manufacturers Antipsychotic Medications Product Type Table Mergers & Acquisitions Planning Table Johnson and Johnson Company Profile Figure Antipsychotic Medications Product Picture and Specifications of Johnson and Johnson Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson and Johnson Antipsychotic Medications Market Share (2018-2020) Table Johnson and Johnson Main Business Table Johnson and Johnson Recent Development Table Eli Lilly Company Profile Figure Antipsychotic Medications Product Picture and Specifications of Eli Lilly Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eli Lilly Antipsychotic Medications Market Share (2018-2020) Table Eli Lilly Main Business Table Eli Lilly Recent Development Table Bristol-Myers Squibb Company Profile Figure Antipsychotic Medications Product Picture and Specifications of Bristol-Myers Squibb Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb Antipsychotic Medications Market Share (2018-2020) Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table AstraZeneca Company Profile Figure Antipsychotic Medications Product Picture and Specifications of AstraZeneca Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure AstraZeneca Antipsychotic Medications Market Share (2018-2020) Table AstraZeneca Main Business Table AstraZeneca Recent Development Table Novartis Company Profile Figure Antipsychotic Medications Product Picture and Specifications of Novartis Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis Antipsychotic Medications Market Share (2018-2020) Table Novartis Main Business Table Novartis Recent Development Table Allergan Company Profile Figure Antipsychotic Medications Product Picture and Specifications of Allergan Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure Allergan Antipsychotic Medications Market Share (2018-2020) Table Allergan Main Business Table Allergan Recent Development Table Pfizer Company Profile Figure Antipsychotic Medications Product Picture and Specifications of Pfizer Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer Antipsychotic Medications Market Share (2018-2020) Table Pfizer Main Business Table Pfizer Recent Development Table GlaxoSmithKline Company Profile Figure Antipsychotic Medications Product Picture and Specifications of GlaxoSmithKline Table Antipsychotic Medications Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline Antipsychotic Medications Market Share (2018-2020) Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Global Antipsychotic Medications Sales (K Units) by Region (2015-2020) Table Global Antipsychotic Medications Sales Market Share by Region (2015-2019) Figure Global Antipsychotic Medications Sales Market Share by Region (2015-2019) Figure Global Antipsychotic Medications Sales Market Share by Region in 2018 Table Global Antipsychotic Medications Revenue (Million US$) by Region (2015-2020) Table Global Antipsychotic Medications Revenue Market Share by Region (2015-2020) Figure Global Antipsychotic Medications Revenue Market Share by Region (2015-2020) Figure Global Antipsychotic Medications Revenue Market Share by Region in 2019 Table Global Antipsychotic Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Antipsychotic Medications Sales (K Units) Growth Rate (2015-2020) Figure Europe Antipsychotic Medications Sales (K Units) Growth Rate (2015-2020) Table Europe Antipsychotic Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Antipsychotic Medications Sales (K Units) Growth Rate (2015-2020) Table Japan Antipsychotic Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Antipsychotic Medications Sales (K Units) Growth Rate (2015-2020) Table China Antipsychotic Medications Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Antipsychotic Medications Sales by Type (2015-2020) Table Global Antipsychotic Medications Sales Market Share by Type (2015-2020) Figure Global Antipsychotic Medications Sales Market Share by Type in 2019 Table Global Antipsychotic Medications Revenue by Type (2015-2020) Table Global Antipsychotic Medications Revenue Market Share by Type (2015-2020) Figure Global Antipsychotic Medications Revenue Market Share by Type in 2019 Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Sales Growth Rate (2015-2025) Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Price (2015-2020) Figure Global Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Sales Growth Rate (2015-2025) Figure Global Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Price (2015-2020) Figure Global Tricyclic Antidepressants (TCAs) Sales Growth Rate (2015-2025) Figure Global Tricyclic Antidepressants (TCAs) Price (2015-2020) Figure Global Monoamine Oxidase Inhibitors (MAOIs) Sales Growth Rate (2015-2025) Figure Global Monoamine Oxidase Inhibitors (MAOIs) Price (2015-2020) Figure Global Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Sales Growth Rate (2015-2025) Figure Global Reversible Inhibitors of Monoamine Oxidase-A (RIMA) Price (2015-2020) Figure Global Tetracyclic Antidepressants (TeCAs) Sales Growth Rate (2015-2025) Figure Global Tetracyclic Antidepressants (TeCAs) Price (2015-2020) Figure Global Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Sales Growth Rate (2015-2025) Figure Global Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs) Price (2015-2020) Table Global Antipsychotic Medications Sales Market Share by Application (2015-2020) Figure Global Antipsychotic Medications Sales Market Share by Application in 2019 Figure Global Hospital Pharmacies Sales Growth Rate (2015-2025) Figure Global Drug Stores Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Antipsychotic Medications Table Key Players of Downstream Markets Figure Sales Channel Figure Global Antipsychotic Medications Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Antipsychotic Medications Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Antipsychotic Medications Price and Trend Forecast (2020-2025) Table Global Antipsychotic Medications Sales (K Units) Forecast by Region (2020-2025) Figure Global Antipsychotic Medications Production Market Share Forecast by Region (2020-2025) Figure North America Antipsychotic Medications Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Antipsychotic Medications Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Antipsychotic Medications Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Antipsychotic Medications Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Antipsychotic Medications Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Antipsychotic Medications Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Antipsychotic Medications Production (K Units) Growth Rate Forecast (2020-2025) Figure China Antipsychotic Medications Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Johnson and Johnson Eli Lilly Bristol-Myers Squibb AstraZeneca Novartis Allergan